Inspire Medical Systems EBITDA Margin 2017-2025 | INSP
Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for Inspire Medical Systems (INSP) over the last 10 years. The current EBITDA margin for Inspire Medical Systems as of March 31, 2025 is .
| Inspire Medical Systems EBITDA Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM EBITDA | EBITDA Margin |
| 2025-03-31 | $0.84B | $0.05B | 6.07% |
| 2024-12-31 | $0.80B | $0.03B | 4.23% |
| 2024-09-30 | $0.76B | $0.01B | 1.19% |
| 2024-06-30 | $0.71B | $-0.02B | -2.55% |
| 2024-03-31 | $0.66B | $-0.04B | -5.75% |
| 2023-12-31 | $0.63B | $-0.04B | -6.40% |
| 2023-09-30 | $0.57B | $-0.05B | -8.42% |
| 2023-06-30 | $0.53B | $-0.05B | -9.89% |
| 2023-03-31 | $0.47B | $-0.05B | -10.73% |
| 2022-12-31 | $0.41B | $-0.05B | -11.55% |
| 2022-09-30 | $0.35B | $-0.05B | -13.83% |
| 2022-06-30 | $0.30B | $-0.04B | -13.33% |
| 2022-03-31 | $0.26B | $-0.04B | -14.50% |
| 2021-12-31 | $0.23B | $-0.04B | -15.88% |
| 2021-09-30 | $0.20B | $-0.04B | -21.39% |
| 2021-06-30 | $0.18B | $-0.04B | -25.14% |
| 2021-03-31 | $0.13B | $-0.06B | -41.04% |
| 2020-12-31 | $0.12B | $-0.06B | -48.70% |
| 2020-09-30 | $0.10B | $-0.06B | -60.42% |
| 2020-06-30 | $0.08B | $-0.06B | -70.37% |
| 2020-03-31 | $0.09B | $-0.04B | -48.28% |
| 2019-12-31 | $0.08B | $-0.04B | -42.68% |
| 2019-09-30 | $0.07B | $-0.03B | -43.06% |
| 2019-06-30 | $0.06B | $-0.03B | -40.63% |
| 2019-03-31 | $0.06B | $-0.02B | -40.35% |
| 2018-12-31 | $0.05B | $-0.02B | -37.25% |
| 2018-09-30 | $0.04B | $-0.02B | -40.91% |
| 2018-06-30 | $0.04B | $-0.02B | -44.74% |
| 2018-03-31 | $0.03B | $-0.02B | -48.48% |
| 2017-12-31 | $0.03B | $-0.02B | -53.57% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $3.905B | $0.803B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $46.313B | 58.92 |
| Tempus AI (TEM) | United States | $11.516B | 0.00 |
| Doximity (DOCS) | United States | $11.474B | 53.12 |
| Hims & Hers Health (HIMS) | United States | $11.060B | 114.91 |
| IRhythm Technologies (IRTC) | United States | $4.939B | 0.00 |
| Hinge Health (HNGE) | United States | $3.629B | 0.00 |
| Privia Health (PRVA) | United States | $2.682B | 183.33 |
| Enovis (ENOV) | United States | $1.815B | 10.12 |
| Phreesia (PHR) | United States | $1.695B | 0.00 |
| Schrodinger (SDGR) | United States | $1.512B | 0.00 |
| 10x Genomics (TXG) | United States | $1.444B | 0.00 |
| Clover Health Investments (CLOV) | United States | $1.405B | 0.00 |
| Azenta (AZTA) | United States | $1.400B | 65.08 |
| Omnicell (OMCL) | United States | $1.376B | 24.28 |
| Evolent Health (EVH) | United States | $1.310B | 111.60 |
| Claritev (CTEV) | United States | $0.716B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.599B | 0.00 |
| Veradigm (MDRX) | United States | $0.498B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.485B | 0.00 |
| Talkspace (TALK) | United States | $0.463B | 138.50 |
| Standard BioTools (LAB) | United States | $0.452B | 0.00 |
| TruBridge (TBRG) | United States | $0.349B | 773.33 |
| Outset Medical (OM) | United States | $0.338B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.265B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.206B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.167B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.127B | 0.00 |
| American Well (AMWL) | United States | $0.124B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.109B | 0.00 |
| Pulmonx (LUNG) | United States | $0.105B | 0.00 |
| CareCloud (CCLD) | United States | $0.102B | 3.89 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.092B | 0.00 |
| 111 (YI) | China | $0.060B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.051B | 0.00 |
| HeartBeam (BEAT) | United States | $0.046B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.046B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.037B | 0.00 |
| Zhongchao (ZCMD) | China | $0.029B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.016B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.010B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.009B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| Movano (MOVE) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |